Recent Updates
Recently added Catalysts
ACIU

AC Immune to Regain Global Rights to Crenezumab And Semorinemab

Monday, January 22, 2024 1 min read
Key Takeaway: AC Immune to Regain Global Rights to Crenezumab And Semorinemab

Full Press Release Details

AC Immune to Regain Global Rights to Crenezumab And Semorinemab.
Tags: ACIU Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Jan 22, 2024